Shareholder Information
ExpreS2ion Biotech Holding AB (company reg. no. 559033-3729) is the Swedish limited liability company listed on Nasdaq First North Growth Market since 2016. ExpreS2ion Biotechnologies ApS (CVR No. 32 77 04 87) is the Danish operational entity, with offices and labs in the Scion DTU Science park just North of Copenhagen, and is 100% owned by ExpreS2ion Biotech Holding AB. ExpreS2ion Biotech is listed on NASDAQ First North Growth Market with ticker symbol EXPRS2.
Additional share information is available on ExpreS2ion's Nasdaq page
Stock chart
List of largest shareholders
| Name | Number of shares held | Share of votes and capital |
|---|---|---|
| Saxo Bank A/S Client Assets | 354895 | 10.05% |
| The Bank of New York Mellon SA/NV | 332,398 | 9.42% |
| BNY Mellon SA/NV for Jyske Bank | 289,393 | 8.20% |
| Summary, shareholders over 5% | 976,686 | 27.67% |
| Remaining shareholders under 5% | 2,553,547 | 72.33% |
| Total 31 March 2026 | 3,530,233 | 100.00% |
Certified Advisor
Redeye Nordic Growth AB
In its role as Certified Adviser, Redeye Nordic Growth AB guides and monitors the company’s compliance with the Nasdaq First North Growth Market rules. Redeye Certified Advisers can be reached at certifiedadviser [a] redeye.se.
I rollen som Certified Adviser vägleder och övervakar Redeye Nordic Growth AB att bolaget lever upp till reglerna på Nasdaq First North Growth Market. Redeye Certified Advisers nås på certifiedadviser [a] redeye.se.
Tel: +45 (0)8 121 576 90
Web: https://www.redeye.se/advisory/certified-adviser